LISA HOLT: Open Payments
NPI 1013772714 · MASON CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,574 in 76 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $596 · 2025 $1,574
Food & beverage: $1,470Education: $104
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $318 |
| Otsuka America Pharmaceutical, Inc. | 12 | $223 |
| ABBVIE INC. | 13 | $223 |
| Janssen Pharmaceuticals, Inc | 9 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $185 |
| Neurocrine BioSciences, Inc. | 7 | $132 |
| Lundbeck LLC | 3 | $78 |
| Axsome Therapeutics, Inc. | 4 | $74 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
Products named: REXULTI, VRAYLAR, CAPLYTA, INGREZZA, INVEGA SUSTENNA, UZEDY, AUSTEDO XR, Auvelity.
Industry payments across IA — which companies pay providers there.
